Benjamin F. Edwards & Company’s Franklin Genomic Advancements ETF HELX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $225K | Buy |
|
|||||
|
2023
Q2 | $234K | Buy |
|
|||||
|
2023
Q1 | $141K | Buy |
|
|||||
|
2022
Q4 | $138K | Sell |
|
|||||
|
2022
Q3 | $139K | Sell |
|
|||||
|
2022
Q2 | $151K | Buy |
|
|||||
|
2022
Q1 | $172K | Buy |
|
|||||
|
2021
Q4 | $186K | Buy |
|
|||||
|
2021
Q3 | $186K | Sell |
|
|||||
|
2021
Q2 | $197K | Buy |
|
|||||
|
2021
Q1 | $161K | Sell |
|
|||||
|
2020
Q4 | $181K | Sell |
|
|||||
|
2020
Q3 | $151K | Buy |
|